※ PTMD 2.0 database Online Browse Options

Browse result for Atherosclerosis

※ introduction

    Atherosclerosis is a pattern of the disease arteriosclerosis, characterized by development of abnormalities called lesions in walls of arteries. These lesions may lead to narrowing of the arterial walls due to buildup of atheromatous plaques. At onset there are usually no symptoms, but if they develop, symptoms generally begin around middle age. In severe cases, it can result in coronary artery disease, stroke, peripheral artery disease, or kidney disorders, depending on which body part(s) the affected arteries are located in the body. The exact cause of atherosclerosis is unknown and is proposed to be multifactorial. Risk factors include abnormal cholesterol levels, elevated levels of inflammatory biomarkers, high blood pressure, diabetes, smoking (both active and passive smoking), obesity, genetic factors, family history, lifestyle habits, and an unhealthy diet. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. The narrowing of arteries limits the flow of oxygen-rich blood to parts of the body. Diagnosis is based upon a physical exam, electrocardiogram, and exercise stress test, among others. Prevention guidelines include, eating a healthy diet, exercising, not smoking, and maintaining normal body weight. Treatment of established disease may include medications to lower cholesterol such as statins, blood pressure medication, and anticoagulant therapies to reduce the risk of blood clot formation. As the disease state progresses more invasive strategies are applied such as percutaneous coronary intervention, coronary artery bypass graft, or carotid endarterectomy. Genetic factors are also strongly implicated in the disease process; it is not entirely based on lifestyle choices. Atherosclerosis generally starts when a person is young and worsens with age. Almost all people are affected to some degree by the age of 65. It is the number one cause of death and disability in developed countries. Though it was first described in 1575, there is evidence suggesting that this disease state is genetically inherent in the broader human population, with its origins tracing back to genetic mutations that may have occurred more than two million years ago during the evolution of hominin ancestors of modern human beings.

Reference
Wiki: Atherosclerosis



PTMD IDUniProt AccessionEntrez IDGene NameProtein NameOrganism
PTMD00322P254907528
YY1
Transcriptional repressor protein YY1
Homo sapiens
PTMD00091Q96EB623411
SIRT1
NAD-dependent protein deacetylase sirtuin-1 [Cleaved into: SirtT1 75 kDa fragment ]
Homo sapiens
PTMD00055P047923315
HSPB1
Heat shock protein beta-1
Homo sapiens
PTMD00031P465271027
CDKN1B
Cyclin-dependent kinase inhibitor 1B
Homo sapiens
PTMD00097Q141459817
KEAP1
Kelch-like ECH-associated protein 1
Homo sapiens
PTMD01370P072375034
P4HB
Protein disulfide-isomerase
Homo sapiens
PTMD01739Q1313310062
NR1H3
Oxysterols receptor LXR-alpha
Homo sapiens
PTMD01772Q166494783
NFIL3
Nuclear factor interleukin-3-regulated protein
Homo sapiens
PTMD01378G1T56710034
RHOA
Transforming protein RhoA
Oryctolagus cuniculus
PTMD01379G1SY93
RAC1
Rac family small GTPase 1
Oryctolagus cuniculus
PTMD01385P3723819016
Pparg
Peroxisome proliferator-activated receptor gamma
Mus musculus
PTMD01698P7031318127
Nos3
Nitric oxide synthase 3
Mus musculus
PTMD01792Q6085519766
Ripk1
Receptor-interacting serine/threonine-protein kinase 1
Mus musculus
PTMD01829Q8C6M174270
Usp20
Ubiquitin carboxyl-terminal hydrolase 20
Mus musculus
PTMD01843Q8VCN510786
Cth
Cystathionine gamma-lyase
Mus musculus
PTMD01922Q9R21021425
Tfeb
Transcription factor EB
Mus musculus
PTMD01954Q9Z0Y922259
Nr1h3
Oxysterols receptor LXR-alpha
Mus musculus